Clinical indicators and coronary angiographic features of expansive arterial remodelling in patients with abdominal aortic aneurysms.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 05 05 2019
accepted: 01 07 2019
entrez: 17 7 2019
pubmed: 17 7 2019
medline: 17 3 2020
Statut: epublish

Résumé

The co-existence of expansive arterial remodelling in both coronary arteries (CAs) and the abdominal aorta has already been reported, although the clinical indicators and quantitative analysis have not been well studied. We therefore aimed to clarify the clinical and anatomical characteristics of patients with abdominal aortic aneurysms (AAAs). 123 AAA patients who underwent coronary angiography were compared to 123 control patients selected by propensity score matching. CA diameters of all 3 vessels were measured by quantitative coronary angiographic analysis. Coronary artery ectasia (CAE) was defined as local or generalized aneurysmal change of the CAs. Excessive expansive CA remodelling was defined as the maximal diameter of the right or left circumflex artery in the upper 75th percentile (>4.8 mm). Multivariable logistic regression analyses were used to determine predictors of CAE and excessive expansive CA remodelling. The prevalences of CAE and excessive expansive CA remodelling were significantly higher in the AAA group than in the non-AAA group (28% vs. 8% and 31% vs. 19%; both p<0.05). On multivariable analysis, the presence of AAA (odds ratio (OR), 4.56; 95% confidence intervals (95%CI) 2.18-10.4) and body mass index (BMI) (OR, 1.11; 95%CI 1.03-1.21) were independently associated with CAE, and higher high-sensitivity C-reactive protein (OR, 2.19; 95%CI 1.08-4.52) and BMI (OR, 1.11; 95%CI 1.02-1.21) were independently associated with excessive expansive CA remodelling. In conclusions, this study showed a higher prevalence of ectatic CA disease in AAA patients and suggests that higher inflammation and obesity are associated with expansive arterial remodelling in coronary arteries.

Identifiants

pubmed: 31310617
doi: 10.1371/journal.pone.0219730
pii: PONE-D-19-12700
pmc: PMC6634394
doi:

Substances chimiques

C-Reactive Protein 9007-41-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0219730

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Cardiovasc Pathol. 2004 Nov-Dec;13(6):313-6
pubmed: 15556777
Circulation. 1999 Jan 5-12;99(1):96-104
pubmed: 9884385
Coron Artery Dis. 2008 Dec;19(8):559-63
pubmed: 19005290
Circ Cardiovasc Interv. 2016 Oct;9(10):
pubmed: 27733430
Ann N Y Acad Sci. 1999 Jun 30;878:212-27
pubmed: 10415733
Cardiol Young. 2018 May;28(5):739-742
pubmed: 29455693
Ann N Y Acad Sci. 1996 Nov 18;800:157-74
pubmed: 8958991
Atherosclerosis. 2005 Apr;179(2):353-9
pubmed: 15777553
J Am Coll Cardiol. 2001 Aug;38(2):297-306
pubmed: 11499716
Coron Artery Dis. 2019 May;30(3):211-215
pubmed: 30741741
Heart. 1997 Aug;78(2):136-41
pubmed: 9326986
J Geriatr Cardiol. 2013 Mar;10(1):10-5
pubmed: 23610568
Br J Surg. 2014 Oct;101(11):1358-72
pubmed: 25131707
BMC Cardiovasc Disord. 2018 May 22;18(1):102
pubmed: 29788926
Am J Cardiol. 1976 Feb;37(2):217-22
pubmed: 1108631
Circulation. 1983 Jan;67(1):134-8
pubmed: 6847792
Int J Cardiol. 2008 Nov 28;130(3):335-43
pubmed: 18694609
Am Heart J. 1993 Jan;125(1):86-92
pubmed: 8417547
Circulation. 2014 Sep 9;130(11 Suppl 1):S51-9
pubmed: 25200056
J Am Heart Assoc. 2012 Dec;1(6):e000885
pubmed: 23316310
Am J Cardiol. 2004 Dec 1;94(11):1433-5
pubmed: 15566920
Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1458-64
pubmed: 19608970
J Am Coll Cardiol. 2006 Apr 18;47(8 Suppl):C13-8
pubmed: 16631505
Circulation. 2017 Mar 7;135(10):e146-e603
pubmed: 28122885
Cardiovasc Pathol. 2018 Jul - Aug;35:37-47
pubmed: 29772448

Auteurs

Hirohisa Endo (H)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Hongo, Bunkyo-ku, Tokyo, Japan.

Tomotaka Dohi (T)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Hongo, Bunkyo-ku, Tokyo, Japan.

Shizuyuki Dohi (S)

Department of Cardiovascular Surgery, Juntendo University Graduate School of Medicine, Hongo, Bunkyo-ku, Tokyo, Japan.

Hideki Wada (H)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Hongo, Bunkyo-ku, Tokyo, Japan.

Shinichiro Doi (S)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Hongo, Bunkyo-ku, Tokyo, Japan.

Yoshiteru Kato (Y)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Hongo, Bunkyo-ku, Tokyo, Japan.

Iwao Okai (I)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Hongo, Bunkyo-ku, Tokyo, Japan.

Hiroshi Iwata (H)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Hongo, Bunkyo-ku, Tokyo, Japan.

Shinya Okazaki (S)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Hongo, Bunkyo-ku, Tokyo, Japan.

Kikuo Isoda (K)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Hongo, Bunkyo-ku, Tokyo, Japan.

Taira Yamamoto (T)

Department of Cardiovascular Surgery, Juntendo University Graduate School of Medicine, Hongo, Bunkyo-ku, Tokyo, Japan.

Katsumi Miyauchi (K)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Hongo, Bunkyo-ku, Tokyo, Japan.

Atsushi Amano (A)

Department of Cardiovascular Surgery, Juntendo University Graduate School of Medicine, Hongo, Bunkyo-ku, Tokyo, Japan.

Hiroyuki Daida (H)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Hongo, Bunkyo-ku, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH